(Q40708171)

English

Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia.

scientific article published on 17 May 2016

In more languages
default for all languages
No label defined

No description defined

Statements

Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit